Cell Line Development & Engineering Europe is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Mark (Mao Xiang) Chen
Manager, Cell Line Development, Cell and Gene Therapy CMC, at GlaxoSmithKline R&D


Mark (Mao Xiang) obtained his PhD in genetics in Prof Barry Holland’s laboratory at the University of Leicester, and postdoc in signal transduction at the MRC Protein Phosphorylation Unit at the University of Dundee, UK. For the last 20 years he worked in GSK on constructing biological reagents and high throughput assays for multiple therapeutic indications. Recently he led the Cell Line Development group in Cell and Gene Therapy CMC in the establishment of viral vector stable producer cell line capability.

Mark (Mao Xiang) Chen's Network

Agenda Sessions

  • High Titre Stable Suspension Lentiviral Vector Producer Cell Lines Using Bacterial Artificial Chromosome (BAC)

    , 12:40